Table 1_Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study.docx

Table 1_Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study.docx

Background<p>Unresectable hepatocellular carcinoma (HCC) presents significant treatment challenges. While locoregional therapies (LT) and tyrosine kinase inhibitors (TKI) offer some benefits, prognosis remains poor. Immune checkpoint inhibitors (ICI) have shown promise in other oncological set...

Full description

Saved in:
Bibliographic Details
Main Author: Junfeng Bu (12439798) (author)
Other Authors: Zihan Li (8827331) (author), Die Hu (160944) (author), Ling Lan (226957) (author), Jiwei Huang (429860) (author), Xin Wang (91924) (author), Qiu Li (2127361) (author), Jin Zhou (90734) (author), Yong Zeng (203681) (author)
Published: 2025
Subjects:
Oncology and Carcinogenesis not elsewhere classified
unresectable hepatocellular carcinoma
locoregional therapy
tyrosine kinase inhibitor
immune checkpoint inhibitor
system therapy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items